Carmignac Gestion Chemo Centryx, Inc. Transaction History

Carmignac Gestion

$5.82 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $232,989 - $321,303	-4,931 Reduced 8.44%	53,465 $3.31 Million
Q2 2020 Aug 13, 2020	SELL	$38.58 - $65.07 $172,606 - $291,123	-4,474 Reduced 7.12%	58,396 $3.36 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $593,656 - $921,047	18,138 Added 40.55%	62,870 $2.53 Million
Q4 2019 Feb 13, 2020	SELL	$6.81 - $39.55 $15.7 Million - $91.5 Million	-2,312,471 Reduced 98.1%	44,732 $1.77 Million
Q3 2019 Nov 13, 2019	BUY	$6.47 - $8.96 $3.08 Million - $4.26 Million	475,594 Added 25.28%	2,357,203 $16 Million
Q2 2019 Aug 13, 2019	SELL	$8.31 - $14.85 $698,289 - $1.25 Million	-84,030 Reduced 4.27%	1,881,609 $17.5 Million
Q1 2019 May 14, 2019	BUY	$10.01 - $13.89 $7.42 Million - $10.3 Million	741,210 Added 60.54%	1,965,639 $27.3 Million
Q4 2018 Feb 13, 2019	SELL	$9.15 - $12.26 $704,376 - $943,787	-76,981 Reduced 5.92%	1,224,429 $13.4 Million
Q3 2018 Nov 13, 2018	BUY	$10.49 - $13.72 $2.89 Million - $3.78 Million	275,273 Added 26.83%	1,301,410 $16.5 Million
Q2 2018 Aug 13, 2018	BUY	$10.62 - $13.98 $6.75 Million - $8.89 Million	636,040 Added 163.05%	1,026,137 $13.5 Million
Q1 2018 May 14, 2018	BUY	$5.9 - $14.99 $2.3 Million - $5.85 Million	390,097 New	390,097 $5.31 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.